News and Events Recent News Mar 18, 2019 Arrowhead Pharmaceuticals Files IND for Pivotal Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease Mar 11, 2019 Arrowhead Pharmaceuticals Begins Dosing in Phase 1 Study of ARO-APOC3 for Treatment of Hypertriglyceridemia Mar 1, 2019 Arrowhead Pharmaceuticals to Present at Upcoming March 2019 Conferences View More » Recent Events Apr 10, 2019 The EASL International Liver Congress 2019 Apr 3, 2019 AACR Annual Meeting 2019 Mar 27, 2019 - Mar 30, 2019 CSHL Meeting: RNA & Oligonucleotide Therapeutics View More »
Mar 18, 2019 Arrowhead Pharmaceuticals Files IND for Pivotal Phase 2/3 Study of ARO-AAT for Treatment of Alpha-1 Liver Disease
Mar 11, 2019 Arrowhead Pharmaceuticals Begins Dosing in Phase 1 Study of ARO-APOC3 for Treatment of Hypertriglyceridemia